# Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

> **NCT01146834** · PHASE3 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 47 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** bortezomib (Velcade)
- **DRUG:** cyclophosphamide
- **DRUG:** G-CSF
- **DRUG:** Plerixafor

## Key facts

- **NCT ID:** NCT01146834
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2019-02-04
- **Final completion:** 2019-02-04
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2019-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01146834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01146834, "Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01146834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*